Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics International, Australian Organizations Launching A$4M Research Facility

NEW YORK – Proteomics International said Tuesday that it has partnered with Bioplatforms Australia and the University of Western Australia to launch a laboratory focused on research into clinical and agricultural protein biomarkers. Bioplatforms Australia invests in the life sciences market with a focus on genomics, proteomics, metabolomics, and bioinformatics.

The three entities will invest more than A$4 million ($2.7M) over the next four years to develop the lab, which will be housed in the Western Australian Proteomic Facility and run by Proteomics International and the University of Western Australia.

The partners will investigate protein markers with applications in medicine as well as agricultural, environmental, and marine science and provide expertise for Western Australia-based researchers.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.